[1] Bray F, Ferlay J, Soerjomataram I,etal. Global cancer sta-tistics 2018: GLOBOCAN estimates of incidence and mor-tality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2018,68(6):394-424. [2] Mao Q, Jiang F, Yin R,et al. Interplay between the lung microbiome and lung cancer [J]. Cancer Lett, 2018,415: 40-48. [3] Lam SY, Yu J, Wong SH,et al. The gastrointestinal mi-crobiota and its role in oncogenesis [J]. Best Pract Res Clin Gastroenterol, 2017,31(6):607-618. [4] Fernandez MF, Reina-Perez I, Astorga JM,et al. Breast Cancer and Its Relationship with the Microbiota [J]. Int J Environ Res Public Health,2018,15(8):pii:E1747. [5] Zhang WQ, Zhao SK, Luo JW,et al. Alterations of fecal bacterial communities in patients with lung cancer [J]. Am J Transl Res, 2018,10(10):3171-3185. [6] Gui QF, Lu HF, Zhang CX,et al. Well-balanced com-mensal microbiota contributes to anti-cancer response in a lung cancer mouse model [J]. Genet Mol Res, 2015,14(2): 5642-5651. [7] Routy B, Le Chatelier E, Derosa L,et al. Gut microbi-ome influences efficacy of PD-1-based immunotherapy against epithelial tumors [J]. Science, 2018,359(6371):91-97. [8] Jin Y, Dong H, Xia L, et al. The Diversity of Gut Mi-crobiome is Associated With Favorable Responses to Anti-Programmed Death 1 Immunotherapy in Chinese Patients With NSCLC [J]. J Thorac Oncol, 2019,14(8):1378-1389. [9] Sancho A, Carrera S, Arietaleanizbeascoa M, et al. Su-pervised physical exercise to improve the quality of life of cancer patients: the EFICANCER randomised controlled trial [J]. BMC Cancer, 2015,15:40. [10] Louis P, Flint HJ. Formation of propionate and butyrate by the human colonic microbiota [J]. Environ Microbiol, 2017,19(1):29-41. [11] Tabuchi Y, Arai Y, Kondo T,et al. Identification of genes responsive to sodium butyrate in colonic epithelial cells [J]. Biochem Biophys Res Commun, 2002,293(4):1287-1294.